Ora, Inc., the world’s leading independent, full- service ophthalmic contract research organization (CRO) and product development firm, announced today that they are the exclusive sponsor for the upcoming Ophthalmology Innovation Summit (OIS) during ASCRS 2014 in Boston, MA.
Presenting at the meeting will be two co-moderators, a prestigious group of panelists including several physicians, a representative from the FDA, and Ora executive, Aron Shapiro.
Aron Shapiro leads Ora’s business unit that supports clients as they develop products for a number of therapeutic areas including retina, glaucoma, infection, inflammation, and refractive disorders, as well as diagnostic and surgical devices. He consults for venture capital investors and strategic acquirers throughout the life cycle of ophthalmic assets. Mr. Shapiro is widely published and writes a monthly column in Retina Today.
The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation
Pascale Communications, LLC